The impact of the COVID-19 pandemic on dyslipidemia in peritoneal dialysis patients
Our findings underscore the significant impact of COVID-19 pandemic-related disruptions in the healthcare system and the subsequent management strategies on dyslipidemia in PD patients while not affecting dysglycemia. These results provide valuable insights for healthcare professionals to enhance their strategies and interventions for CKD patients undergoing PD during a pandemic.
Authors
- Chih‐Ching Lin (ORCID: https://orcid.org/0000-0003-2338-3561)
- Po-Yen Lu
- Chyong‐Mei Chen (ORCID: https://orcid.org/0000-0001-6824-4819)
- Ann Charis Tan (ORCID: https://orcid.org/0000-0002-7776-5613)
- Szu‐Yuan Li (ORCID: https://orcid.org/0000-0002-3639-8212)
- Fan‐Yu Chen
- S.-Y. Li
- Yi‐Fang Chuang (ORCID: https://orcid.org/0000-0002-5421-9855)
- Jen-En Tsai
- Yu‐Hsuan Li
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1097/jcma.0000000000001170
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28